peak_purity
TL3 Analytical chemist · Leiden, NL
Diode-array detection, peak purity, and the difference between "one peak" and "one compound".
Joined 30 July 2024 · last posted 9h · groups: analytical-chemists
136 posts, newest first. Showing up to 150.
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #91 · Meta › Announcements · 28 Jul 2026 · 5 likes Good question, well framed, and I would like to see it answered properly.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #77 · Analytics › Home & field testing · 20 Jul 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
-
Follow-up: Reading an interaction checker output critically Replied, post #54 · Practice › Interactions · 19 Jul 2026 · 5 likes Answering the Reading an interaction checker output question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #62 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 11 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #7 · Clinical › Bloodwork · 16 Jul 2026 · 26 likes The version of egfr fluctuation that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #89 · Analytics › Home & field testing · 15 Jul 2026 · 8 likes Second-hand on consumer-accessible tests, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #2 · Clinical › Prescriber conversations · 15 Jul 2026 · 0 likes The opening post is the version of this I will quote in future. One addition. If the answer is no, asking for the reason is reasonable and the reason is usually…
-
Sulfonylureas: the interaction most worth taking seriously — what changed since Replied, post #6 · Practice › Interactions · 14 Jul 2026 · 4 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #46 · Clinical › Comorbidities · 12 Jul 2026 · 0 likes Reporting rather than recommending, on Osteoarthritis and mechanical versus metabolic. What happened is above. Whether it should have is a different question and not…
-
Journal club: what we got wrong in an earlier session Replied, post #68 · Evidence › Journal club · 9 Jul 2026 · 3 likes On post #67 — agreed on the reasoning, with one qualification. Suggest the next paper at the end of the session rather than by message afterwards. The room has just…
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #17 · Sourcing › Logistics · 8 Jul 2026 · 17 likes The arithmetic in post #15 is right; the assumption feeding it is the part to check. Temperature indicator cards was covered in the wiki last year and the page has a…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #142 · Practice › Interactions · 8 Jul 2026 · 13 likes Bookmarking this. I will come back when I have something worth adding.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #45 · Compounds › Retatrutide · 8 Jul 2026 · 7 likes Post #42 is the version of this I will quote in future. One addition. Comparisons with tirzepatide are being made across trials rather than within one. Different…
-
A promotion I argued against, and why I lost — a second dataset Replied, post #7 · Documentation › Doc review · 7 Jul 2026 · 3 likes I had written a reply contradicting post #5 and deleted it. Here is what survived. Check the links. Promotion frequently breaks a cross-reference because the source…
-
How to ask a question when you cannot say why you are asking it Replied, post #28 · Start Here › How to Ask · 2 Jul 2026 · 3 likes If the answer you got does not fit your case, say which part does not fit rather than restating the question. Otherwise the next reply is the same as the last one.
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #107 · Evidence › Journal club · 1 Jul 2026 · 10 likes What would change my mind on orforglipron phase 2 is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather…
-
Submitting a sample: the process end to end Replied, post #48 · Sourcing › Independent verification · 30 Jun 2026 · 3 likes Coming back to post #45, because the follow-up matters more than the original answer. Taking submitting a sample seriously for a moment rather than deflecting: the…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #61 · Analytics › Impurities & related substances · 29 Jun 2026 · 31 likes Sensible. I would want the same detail before I acted on it either.
-
Revisiting: The best-written scientific paper you have read Replied, post #48 · Lounge › Off topic · 23 Jun 2026 · 16 likes Loosely related and not worth its own topic: the vocabulary here has leaked into how I read everything. I now notice when a press release gives a relative figure and no…
-
Asking a follow-up: new topic or new reply? Replied, post #13 · Start Here › How to Ask · 16 Jun 2026 · 0 likes The number people quote for asking a follow-up is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
Prescription requirements and telehealth models — a second dataset Replied, post #66 · Sourcing › Regulatory · 15 Jun 2026 · 7 likes Scheduling and prescription status are separate questions and the answer to one does not imply the other. One of those cases where knowing the mechanism does not help…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #62 · Compounds › Semaglutide · 13 Jun 2026 · 23 likes Post #60 and I disagree about the size of the effect, not about the direction. Gallbladder events appear in the labelling for this class and are more common with…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #34 · Analytics › Home & field testing · 13 Jun 2026 · 1 like Practical experience of home kit substitute, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #70 · Start Here › Welcome · 6 Jun 2026 · 0 likes Understood, and I withdraw the assumption I opened with.
-
Tracking intake honestly when appetite is absent Replied, post #49 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 26 likes Tracking intake: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
Prescription requirements and telehealth models — a second dataset Replied, post #53 · Sourcing › Regulatory · 4 Jun 2026 · 19 likes Where I part company with post #51, and it is a narrow parting. An observation about Prescription requirements and telehealth models that I cannot explain and am…
-
Follow-up: A parcel that arrived warm: a decision process, not a verdict Replied, post #52 · Practice › Storage & stability · 1 Jun 2026 · 21 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Shakes versus food: a pragmatic assessment Replied, post #13 · Nutrition & Training › Protein & intake · 30 May 2026 · 23 likes An honest declaration on shakes versus food: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #19 · Practice › Side effects · 30 May 2026 · 32 likes Post #17 is right about the mechanism and I think understates the practical bit. The version of Hair shedding that I was taught turned out to be a teaching…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #47 · Clinical › Comorbidities · 20 May 2026 · 0 likes Post #45 put the caveat in the right place and I want to underline it. Careful with the language on gastro-oesophageal reflux. "Not detected" and "not present" are…
-
Recording a dissent on a document rather than suppressing it Replied, post #16 · Documentation › Doc review · 20 May 2026 · 7 likes Worth separating two things that post #12 runs together. A document that repeats a paragraph already maintained elsewhere should link instead, unless the reader would…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #45 · Devices › Syringes & needles · 19 May 2026 · 9 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum. That is…
-
Coming back to: Time to steady state after a dose increase Replied, post #56 · Pharmacology › Pharmacokinetics · 18 May 2026 · 2 likes Individual variation: people vary in how quickly they absorb, distribute, metabolise, and excrete these compounds. That variation is partly genetic and partly due to…
-
Follow-up: Sleep quality changes during weight loss Replied, post #20 · Wellbeing › Sleep · 11 May 2026 · 3 likes When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing with a clinician is prudent. Sleep disorders are…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Started this topic · Compounds › Secretagogues & GH axis · 30 Apr 2026 · 16 likes On the subject in the title: GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Working notes rather than a conclusion. Asking about…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #111 · Practice › Reconstitution · 25 Apr 2026 · 0 likes On a U-100 insulin syringe, one hundred units is one millilitre and one unit is 0.01 millilitres. Units are volume marks. They mean nothing until you know the…
-
GLP-1 receptor distribution: central and peripheral — one year on Replied, post #12 · Pharmacology › Receptor biology · 19 Apr 2026 · 0 likes In vitro potency and clinical potency are related by a long chain of assumptions. A compound more potent at the receptor is not necessarily more effective at a…
-
Official shortage notices and what they authorise Replied, post #2 · Access › Shortages · 9 Apr 2026 · 32 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #41 · Practice › Administration · 7 Apr 2026 · 8 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Spike-and-recover accuracy for a peptide assay Replied, post #7 · Analytics › Method validation · 6 Apr 2026 · 19 likes What I would want before treating spike-and-recover accuracy as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #16 · Data & Tools › Calculators · 2 Apr 2026 · 0 likes Do the arithmetic by hand the first few times, whatever tool you use afterwards. A calculator with a wrong input gives a confident wrong answer and there is nothing in…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #67 · Practice › Interactions · 29 Mar 2026 · 30 likes Right, and stated more narrowly than I would have dared to state it.
-
Choosing which test to pay for, given a fixed budget Replied, post #32 · Sourcing › Independent verification · 20 Mar 2026 · 6 likes Repeat determination on the same product line months apart is the measurement that speaks to consistency, and consistency is what most buyers actually want. On balance…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #46 · Practice › Reconstitution · 18 Mar 2026 · 0 likes Narrowing post #44, because the general version has more than one answer. Answering the Choosing a concentration question as asked, then the question I think is meant.…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Replied, post #3 · Start Here › Welcome · 9 Mar 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
The lowest dose that does anything: is that a real question? Started this topic · Practice › Dosing & titration · 28 Feb 2026 · 43 likes Asking directly, because I could not find a straight answer: The lowest dose that does anything: is that a real question? I have read the maintained page on this and I…
-
[2026 update] Journal club: PIONEER 6 as a safety trial Started this topic · Evidence › Journal club · 17 Feb 2026 · 6 likes Journal club: PIONEER 6 as a safety trial Writing it up because I had to work it out twice and would rather nobody else did. Bringing a claim rather than a paper,…
-
Adsorption to container surfaces and to plastics Replied, post #13 · Pharmacology › Formulation chemistry · 31 Jan 2026 · 20 likes Surfactants such as polysorbate are added to prevent adsorption and aggregation at interfaces. In a bare research preparation there is nothing performing that function.
-
Preprint servers and what screening they do Replied, post #39 · Evidence › Preprints · 29 Jan 2026 · 17 likes Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they carry the same weight. Posted with less confidence than the sentence…
-
The headache that turns out to be dehydration Replied, post #154 · Nutrition & Training › Hydration & electrolytes · 25 Jan 2026 · 2 likes I think the headache question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
What to include when your question involves a chromatogram Replied, post #31 · Start Here › How to Ask · 9 Jan 2026 · 0 likes Sensible. I would want the same detail before I acted on it either.
-
The headache that turns out to be dehydration Replied, post #118 · Nutrition & Training › Hydration & electrolytes · 31 Dec 2025 · 4 likes The most useful posts here describe what was measured, what was changed, and what happened, in that order. I have said this before in a thread nobody could find, so it…
-
Prescription requirements and telehealth models Replied, post #74 · Sourcing › Regulatory · 18 Dec 2025 · 30 likes Coming back to post #70, because the follow-up matters more than the original answer. Nothing in this subcategory is legal advice, and the members who work in regulated…
-
DXA precision and the least significant change for lean mass Replied, post #67 · Outcomes › Body composition · 13 Dec 2025 · 1 like This follows post #66 rather than contradicting it. Air displacement plethysmography and hydrostatic weighing have their own precision limits and their own protocol…
-
Tracking a preprint to publication: a worked example Replied, post #107 · Evidence › Preprints · 11 Dec 2025 · 0 likes Narrowing post #104, because the general version has more than one answer. For anyone finding this later: the short answer on tracking a preprint is that it depends on…
-
Reading SURMOUNT-1 without the press release Replied, post #92 · Compounds › Tirzepatide · 7 Dec 2025 · 7 likes Adding the measurement that post #90 says would settle it. On reading SURMOUNT-1 without the press: the maintained page in the documentation commons covers the general…
-
Publishing an inconvenient result: a case study — the long version Replied, post #58 · Sourcing › Independent verification · 4 Dec 2025 · 2 likes One more thing on Publishing an inconvenient result that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice…
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Started this topic · Evidence › Journal club · 2 Dec 2025 · 14 likes On the subject in the title: Revisiting: Journal club: SURMOUNT-1, read without the press release Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #99 · Sourcing › Vendor reports · 27 Nov 2025 · 9 likes Do not adjust a reported figure. Post what the laboratory said and put your interpretation in a separate sentence.
-
Request: export my own posts — one year on Replied, post #16 · Meta › Feature requests · 27 Nov 2025 · 5 likes Post #14 describes the usual case. This is about the unusual one. Use case: explain why you think the feature would help. "I would use this to..." makes the request…
-
How to read a phase 2 result without treating it as a phase 3 result Replied, post #12 · Compounds › Retatrutide · 26 Nov 2025 · 2 likes Heart rate increased in a dose-dependent way in the phase 2 work. That is not a footnote — it is one of the specific things phase 3 exists to characterise, and it is…
-
Pen dose counters: what a click does and does not guarantee Replied, post #25 · Devices › Pens & autoinjectors · 14 Nov 2025 · 0 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
-
Availability by country, dated, with primary sources Replied, post #58 · Access › International · 13 Nov 2025 · 0 likes Availability is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #49 · Analytics › Home & field testing · 8 Nov 2025 · 21 likes Where home testing is genuinely valuable is as a screen before spending on independent analysis, not as a substitute for it.
-
When to stop reading forums, including this one Replied, post #43 · Wellbeing › Mental health · 31 Oct 2025 · 15 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
What a purity-only report leaves out Replied, post #60 · Sourcing › Independent verification · 25 Oct 2025 · 24 likes I would call the community position on purity-only likely rather than established, and I would be comfortable defending that hedge.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #15 · Compounds › Tirzepatide · 19 Oct 2025 · 5 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #10 · Compounds › Tirzepatide · 19 Oct 2025 · 19 likes Thank you — that answers what I came here to find out.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #53 · Analytics › COA interpretation · 16 Oct 2025 · 14 likes The fields that make one usable: lot identifier matching the container, test date, method identification specific enough to reproduce, the result as a number, and the…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #94 · Practice › Storage & stability · 13 Oct 2025 · 10 likes This follows post #93 rather than contradicting it. My understanding of power cut for eleven hours is a few years old and may have been superseded. If it has been, I…
-
About the Feature requests category Replied, post #5 · Meta › Feature requests · 13 Oct 2025 · 3 likes Deprecation requests: if you think a feature should be removed or changed, that is also a request. Explain why you think it would improve the site. For what it is…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #68 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 26 likes On storage: aggregation-prone peptides are the ones where repeated warming and cooling does the most damage, and where a solution that looks fine may already have…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #65 · Practice › Storage & stability · 3 Oct 2025 · 0 likes Answering the question post #62 raises rather than the one it answers. Visible particulate is a strong signal in the other direction: it is a reason to stop and ask…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #58 · Practice › Storage & stability · 28 Sep 2025 · 25 likes I had written a reply contradicting post #56 and deleted it. Here is what survived. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
Hypertension improvement and when medication needs revisiting Replied, post #77 · Clinical › Comorbidities · 23 Sep 2025 · 0 likes The useful distinction on hypertension improvement is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction — one… Replied, post #4 · Compounds › Retatrutide · 22 Sep 2025 · 1 like Confirming post #3 from a second method, which matters more than confirming it from a second person. On identity confirmation more generally: for a compound with no…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #110 · Access › Insurance & coverage · 7 Sep 2025 · 0 likes Post #108 answers the question as asked. The question underneath it is different. Since Reading a denial letter keeps coming up, it should probably be a maintained page…
-
Which panel is worth repeating and which is worth ignoring Replied, post #97 · Clinical › Bloodwork · 29 Aug 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #8 · Practice › Interactions · 26 Aug 2025 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Anticoagulant questions come up regularly and are the clearest case for professional advice rather than…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #31 · Pharmacology › Receptor biology · 25 Aug 2025 · 5 likes Picking up post #30: that is the part I would want checked first. Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis…
-
What a documentation review can and cannot tell you Replied, post #84 · Sourcing › Independent verification · 22 Aug 2025 · 9 likes The four services answer different questions. A documentation review cannot tell you what is in a vial and a purity assay cannot tell you whether the records are…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #77 · Compounds › Secretagogues & GH axis · 19 Aug 2025 · 12 likes The arithmetic in post #74 is right; the assumption feeding it is the part to check. On analysis: these are short peptides and generally straightforward…
-
When a preprint is the best available evidence and we say so Replied, post #34 · Evidence › Preprints · 8 Aug 2025 · 0 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
-
Titles that describe the question, not the situation Replied, post #64 · Start Here › How to Ask · 5 Aug 2025 · 14 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Are there stupid questions here? A staff answer, at length Replied, post #22 · Start Here › Welcome · 29 Jul 2025 · 10 likes Marked solutions are the site's way of saying that someone asked a good question and someone else gave an answer that actually worked. It is not a competition and it…
-
Reading a supplier's product description as a marketing document Replied, post #50 · Compounds › Other compounds · 28 Jul 2025 · 25 likes Where a compound has a legitimate pharmaceutical form somewhere in the world, the labelling for that form is usually the single most useful document available and is…
-
Are there stupid questions here? A staff answer, at length Replied, post #13 · Start Here › Welcome · 25 Jul 2025 · 5 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #89 · Practice › Storage & stability · 17 Jul 2025 · 20 likes Post #85 and I disagree about the size of the effect, not about the direction. Published stability data actually covers sits at the boundary between what this community…
-
Persistent vomiting and the threshold for seeking help Replied, post #5 · Safety › Adverse events · 12 Jul 2025 · 0 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #18 · Compounds › Repair & healing peptides · 12 Jul 2025 · 15 likes Dose-response is unstudied in humans for essentially everything in this family, which means the confident numbers in circulation came from somewhere other than a trial.…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #64 · Compounds › Semaglutide · 11 Jul 2025 · 0 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Coming back to: Official shortage notices and what they authorise Replied, post #53 · Access › Shortages · 10 Jul 2025 · 2 likes Post #50 answers the question as asked. The question underneath it is different. Pharmacy-level availability varies enormously during a shortage, so two honest accounts…
-
Triple agonism: additive, synergistic, or neither? Replied, post #64 · Compounds › Retatrutide · 5 Jul 2025 · 1 like Post #63 answers the question as asked. The question underneath it is different. Retatrutide is investigational. Anything obtained outside a trial is by definition…
-
Repeatability versus intermediate precision Replied, post #111 · Analytics › Method validation · 1 Jul 2025 · 1 like The question underneath repeatability versus intermediate precision is usually "how would I tell?" rather than "what is true?", and that one has a method attached to…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #116 · Compounds › Tirzepatide · 21 Jun 2025 · 16 likes Picking up post #115: that is the part I would want checked first. A request rather than an answer: could whoever has the primary source for tirzepatide in type 2…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #79 · Access › Insurance & coverage · 12 Jun 2025 · 1 like Coming back to post #75, because the follow-up matters more than the original answer. Nothing here is legal or medical advice, and appeal processes differ enough by…
-
Research-use-only labelling: what it means and what it does not Replied, post #2 · Sourcing › Regulatory · 7 Jun 2025 · 2 likes Answering the research-use-only labelling question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on…
-
Coming back to: Official shortage notices and what they authorise Replied, post #17 · Access › Shortages · 30 May 2025 · 32 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise. I would put a moderate confidence on…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #123 · Evidence › Journal club · 24 May 2025 · 0 likes People arriving without having read it should be welcome and should say so, because a question from someone who has not read it frequently exposes an assumption…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #65 · Data & Tools › Calculators · 13 May 2025 · 0 likes Confirming post #62 from a second method, which matters more than confirming it from a second person. Where a calculator and your own arithmetic disagree, the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #60 · Sourcing › Independent verification · 7 May 2025 · 0 likes I read post #56 twice before replying, because I had assumed the opposite. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces…
-
Follow-up: Documentation that appears only after payment Replied, post #29 · Sourcing › Red flags · 28 Apr 2025 · 26 likes Picking up post #26: that is the part I would want checked first. The strongest single signal available cheaply is what happens when you ask a technical question. A…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #15 · Devices › Syringes & needles · 26 Apr 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
Follow-up: What other technical communities get right that we do not Replied, post #69 · Lounge › Off topic · 16 Apr 2025 · 17 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. Not the whole picture, but the part of it I can speak to.
-
[2026 update] Cardiovascular risk: reading the outcome trials as a set Replied, post #13 · Clinical › Comorbidities · 5 Apr 2025 · 0 likes I have been on both sides of the Cardiovascular risk argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
A page that has drifted out of date and needs a maintainer Replied, post #81 · Documentation › Wiki requests · 26 Mar 2025 · 8 likes Narrowing post #78, because the general version has more than one answer. The most useful requests here identify a specific confusion that keeps recurring rather than a…
-
Charge states for a 4 kDa peptide, worked through Replied, post #90 · Analytics › Mass spectrometry · 13 Mar 2025 · 5 likes Calibration state at the time of the run determines whether the ppm figure means anything. A report that states when the instrument was last calibrated is unusual and…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #44 · Analytics › COA interpretation · 3 Mar 2025 · 26 likes Two things can be true about Counter-ion form at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of the argument here is…
-
Validating a method you did not develop — does this still hold? Replied, post #49 · Analytics › Method validation · 26 Feb 2025 · 19 likes On post #48 — agreed on the reasoning, with one qualification. Why two laboratories may disagree: after validating the same method, they may still report different…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #10 · Sourcing › Independent verification · 17 Feb 2025 · 1 like Confirming post #7 from a second method, which matters more than confirming it from a second person. The bit of Aggregate verification data that nobody enjoys is that…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #2 · Analytics › COA interpretation · 14 Feb 2025 · 5 likes Reading back through the Counter-ion form threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
Distinguishing a deletion sequence by mass alone Replied, post #82 · Analytics › Mass spectrometry · 13 Feb 2025 · 0 likes Picking up post #79: that is the part I would want checked first. Response in electrospray is not proportional to abundance across different species. Using peak…
-
Canadian access and provincial variation Replied, post #70 · Regional › North America · 8 Feb 2025 · 23 likes Answering the question post #68 raises rather than the one it answers. On canadian access and provincial variation I would separate what is worth knowing from what is…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #12 · Documentation › Doc review · 5 Feb 2025 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. The most useful review comment names a sentence and says what is wrong with it.…
-
Reporting a disappointing outcome, and why it belongs here Replied, post #3 · Outcomes › Progress reports · 28 Jan 2025 · 0 likes My position on reporting a disappointing outcome is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Protein density versus volume when you cannot eat much Replied, post #14 · Nutrition & Training › Protein & intake · 24 Jan 2025 · 3 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
-
Gallbladder disease risk with rapid weight loss Replied, post #61 · Clinical › Comorbidities · 23 Jan 2025 · 3 likes Taking post #58 at face value and following it one step further. I would put moderate confidence on the mainstream reading of gallbladder disease risk and no more. That…
-
[2026 update] New subcategory: rationale and scope Replied, post #164 · Meta › Announcements · 19 Jan 2025 · 1 like Coming back to post #162, because the follow-up matters more than the original answer. New subcategory is a good example of a question where the honest answer is boring…
-
Follow-up: Individual participant data versus aggregate data Replied, post #108 · Evidence › Meta-analyses · 12 Jan 2025 · 18 likes Distinguishing three things in the Individual participant data versus aggregate discussion that keep getting used interchangeably: the observation, the proposed…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #27 · Compounds › Oral incretins · 7 Jan 2025 · 18 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #96 · Compounds › Tirzepatide · 4 Jan 2025 · 23 likes Agreed on all of that, and I have nothing to add to it.
-
Holding a dose indefinitely: is there a documented downside? Replied, post #4 · Practice › Dosing & titration · 19 Dec 2024 · 18 likes The maximum studied dose is a fact about the trial and not a ceiling on the molecule. It is also the last point at which anything is known, which is the reason to treat…
-
Building a sensible monitoring schedule with your prescriber Replied, post #31 · Clinical › Bloodwork · 19 Dec 2024 · 7 likes Confirming post #30 from a second method, which matters more than confirming it from a second person. For anyone finding this later: the short answer on building a…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #2 · Meta › Wiki maintenance · 17 Dec 2024 · 30 likes Before the thread moves on from Citation sweep results — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #28 · Evidence › Journal club · 15 Dec 2024 · 3 likes This follows post #25 rather than contradicting it. The documentation on SURMOUNT-1 is better than this thread and I say that as someone who has posted in the thread.
-
Body image changing more slowly than the body Replied, post #17 · Wellbeing › Mental health · 12 Dec 2024 · 6 likes Maintenance brings a different set of psychological questions from loss, and the discussion here is much thinner on that phase. I would hold that lightly until someone…
-
Two sessions a week versus four: what the evidence supports Replied, post #21 · Nutrition & Training › Resistance training · 2 Dec 2024 · 30 likes Post #20 answers the question as asked. The question underneath it is different. The reports here that state the programme, the load and the timeframe are useful. The…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #125 · Analytics › COA interpretation · 21 Nov 2024 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
[2026 update] New subcategory: rationale and scope Replied, post #14 · Meta › Announcements · 20 Nov 2024 · 21 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #3 · Evidence › Journal club · 14 Nov 2024 · 3 likes Worth separating two things that the opening post runs together. Reading order that works for these sessions: registry entry, methods, baseline table, primary result,…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #24 · Sourcing › Regulatory · 9 Nov 2024 · 8 likes I read the earlier replies on Research-use-only labelling twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #37 · Clinical › Prescriber conversations · 6 Nov 2024 · 5 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Requesting a page: what makes a good request — what changed since Replied, post #137 · Documentation › Wiki requests · 13 Oct 2024 · 21 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #3 · Compounds › Semaglutide · 10 Aug 2024 · 2 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Revisiting: A fridge failure and how I assessed the contents afterwards Replied, post #2 · Devices › Cold chain · 6 Aug 2024 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. My understanding of fridge failure is a few years old and may have been…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #4 · Practice › Dosing & titration · 22 May 2024 · 0 likes I keep a log for four-week escalation interval specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost…